BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32956608)

  • 1. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
    Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
    Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
    Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
    Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
    Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
    Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
    Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
    J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer's Disease.
    Luo Y; Li D; Liao Y; Cai C; Wu Q; Ke H; Liu X; Li H; Hong H; Xu Y; Wang Q; Fang J; Fang S
    Front Pharmacol; 2020; 11():381. PubMed ID: 32317964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms.
    Bo M; Zhang H; Xu J; Zhao H; Jia X; Wang G; Lu Z
    Front Behav Neurosci; 2022; 16():1061877. PubMed ID: 36560929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kai-xin-san improves cognitive impairment in D-gal and Aβ
    Wang H; Zhou L; Zheng Q; Song Y; Huang W; Yang L; Xiong Y; Cai Z; Chen Y; Yuan J
    J Ethnopharmacol; 2024 Jul; 329():118161. PubMed ID: 38599474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
    Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
    Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
    Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classic Prescription, Kai-Xin-San, Ameliorates Alzheimer's Disease as an Effective Multitarget Treatment: From Neurotransmitter to Protein Signaling Pathway.
    Guo S; Wang J; Xu H; Rong W; Gao C; Yuan Z; Xie F; Bi K; Zhang Z; Li Q
    Oxid Med Cell Longev; 2019; 2019():9096409. PubMed ID: 31354916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The memory enhancement effect of Kai Xin San on cognitive deficit induced by simulated weightlessness in rats.
    Qiong W; Yong-Liang Z; Ying-Hui L; Shan-Guang C; Jiang-Hui G; Yi-Xi C; Ning J; Xin-Min L
    J Ethnopharmacol; 2016 Jul; 187():9-16. PubMed ID: 27103112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
    Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
    J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.
    Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H
    Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Chinese herbal formula Kai-Xin-San on rodent models of depression: A systematic review and meta-analysis.
    Wang YT; Wang XL; Lei L; Guo ZY; Hu D; Wang ZZ; Zhang Y
    J Ethnopharmacol; 2024 Mar; 321():117492. PubMed ID: 38012974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology.
    Guo S; Wang J; Wang Y; Zhang Y; Bi K; Zhang Z; Li Q
    Oxid Med Cell Longev; 2019; 2019():1707218. PubMed ID: 31976026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.
    Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F
    J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway.
    Cao C; Xiao J; Liu M; Ge Z; Huang R; Qi M; Zhu H; Zhu Y; Duan JA
    J Ethnopharmacol; 2018 Oct; 224():554-562. PubMed ID: 29890314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential mechanism of Kaixinsan powder for the same pathogenesis of PTSD and anxiety based on network pharmacology and molecular docking: A review.
    Li WW; Wang J; Wu HB; Qiu ZK
    Medicine (Baltimore); 2023 Nov; 102(46):e35869. PubMed ID: 37986356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.